Cancer Cells Acquire Mitotic Drug Resistance Properties Through Beta I-Tubulin Mutations and Alterations in the Expression of Beta-Tubulin Isotypes

BACKGROUND: Anti-mitotic compounds (microtubule de-stabilizers) such as vincristine and vinblastine have been shown clinically successful in treating various cancers. However, development of drug-resistance cells limits their efficacies in clinical situations. Therefore, experiments were performed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheung, Chun Hei Antonio, Wu, Su-Ying, Lee, Tian-Ren, Chang, Chi-Yen, Wu, Jian-Sung, Hsieh, Hsing-Pang, Chang, Jang-Yang
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933234/
https://www.ncbi.nlm.nih.gov/pubmed/20838440
http://dx.doi.org/10.1371/journal.pone.0012564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933234/
https://www.ncbi.nlm.nih.gov/pubmed/20838440
http://dx.doi.org/10.1371/journal.pone.0012564

Ejemplares similares